Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | CPA3 | P15088 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20943329 | 1.00 | ALDH1A1 (0.51) | ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2 | |
| SCHEMBL22483207 | 0.98 | ALDH1A1 (0.53) | ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2 | |
| SCHEMBL20960093 | 0.94 | ALDH1A1 (0.54) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL20943396 | 0.93 | MEN1 (0.55) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL20943380 | 0.93 | MEN1 (0.55) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL20943382 | 0.90 | ALDH1A1 (0.55) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL3409158 | 0.90 | MEN1 (0.52) | ALDH1A1KMT2AMEN1HPGDFOLH1 | |
| SCHEMBL20943371 | 0.88 | MMP3 (0.47) | ALDH1A1MAPK1L3MBTL1SLC15A1EPHX2 | |
| SCHEMBL8491358 | 0.88 | ALDH1A1 (0.57) | ALDH1A1MAPK1L3MBTL1SLC15A1KMT2A | |
| SCHEMBL4941879 | 0.87 | ALDH1A1 (0.66) | ALDH1A1MAPK1L3MBTL1EPHX2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230286902-A1 | LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-09-14 | — | — | US | disclosed |
| EP-3476832-B1 | CATIONIC LIPID | EISAI R&D MAN CO LTD (JP) | 2023-04-19 | — | — | EP | disclosed |
| US-11472766-B2 | Lipid nanoparticle composition | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-10-18 | — | — | US | disclosed |
| US-20220153686-A1 | LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2022-05-19 | — | — | US | disclosed |
| CN-109311809-B | Cationic lipids | 卫材R&D管理有限公司 | 2022-04-08 | — | — | CN | disclosed |
| US-20190218180-A1 | Cationic Lipid | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20190218180-A1 | Cationic Lipid | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2019-07-18 | — | — | US | disclosed |
| EP-3476832-A1 | CATIONIC LIPID | Eisai R&D Management Co., Ltd. (JP) | 2019-05-01 | — | — | EP | disclosed |
| EP-3476832-A1 | CATIONIC LIPID | Eisai R&D Management Co., Ltd. (JP) | 2019-05-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218180-A1 | Cationic Lipid | NPC1L1, NPC1, LPCAT1 | ALDH1A1 1462/4885MAPK1 1519/4885L3MBTL1 344/4885 |
| US-20230286902-A1 | LIPID NANOPARTICLE COMPOSITION | CETP, NPC1, LCAT | ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885 |
| US-20220153686-A1 | LIPID NANOPARTICLE COMPOSITION | CETP, NPC1, LCAT | ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885 |
| US-11472766-B2 | Lipid nanoparticle composition | CETP, NPC1, LCAT | ALDH1A1 4587/4885MAPK1 3444/4885L3MBTL1 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.